EYE.AX

Nova Eye Medical Limited EYE.AX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode EYE.AX PTX.AX NXS.AX GSS.AX CYP.AX CSX.AX IIQ.AX HMD.AX VIT.AX OSL.AX
6M 47.62 % -6.67 % 51.52 % -43.90 % 25.64 % 79.49 % -9.09 % 148.28 % 0.00 % -15.25 %
YTD -11.43 % -17.65 % 30.43 % -65.15 % 2.08 % 53.85 % -33.96 % 80.00 % -14.63 % -39.46 %
1Y -16.22 % -4.55 % -23.08 % -65.15 % 6.52 % 44.33 % -28.57 % 44.00 % -39.13 % -64.69 %
3Y -37.58 % -76.67 % -80.65 % -70.57 % -26.87 % 29.63 % -39.66 % -71.69 % -92.43 % -88.96 %
5Y -50.26 % -34.38 % -88.00 % -87.43 % -70.39 % -90.57 % -98.44 % -71.69 % -19.54 % -95.86 %
10Y -68.16 % -26.90 % -88.89 % -48.25 % -48.81 % -90.57 % -59.92 % -79.56 % -79.41 % -96.32 %
From the beginning -98.47 % -99.88 % -88.89 % -51.45 % -90.54 % -90.57 % -99.85 % -79.56 % -79.41 % -97.00 %

Dividend

Nova Eye Medical Limited

Prescient Therapeutics Limited

Vitura Health Limited